Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Burd

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Leukemia|April 9, 2016
Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesisG Kong, Y-I Chang, A Damnernsawad, et al.
Molecular Cancer Therapeutics|February 3, 2017
The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint InhibitorsMatthew R Farren, Rebecca C Hennessey, Reena Shakya, et al.
Pigment Cell & Melanoma Research|June 21, 2023
The OSUMMER lines: A series of ultraviolet-accelerated NRAS-mutant mouse melanoma cell lines syngeneic to C57BL/6Brandon M Murphy, Daelin M Jensen, Tiffany E Arnold, et al.
Oncotarget|March 5, 2016
Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cellsDario Palmieri, Mario Scarpa, Anna Tessari, et al.
Brain, Behavior, and Immunity|June 9, 2026
Is a happy marriage a double-edged sword for biological aging? Preliminary evidence for the moderating role of couples' health behaviorsStephanie J Wilson, Annelise A Madison, M Rosie Shrout, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple MyelomaFabienne Lucas, Michael Pennell, Ying Huang, et al.
Nature Medicine|February 21, 2024
Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylationGeorge P Souroullas, William R Jeck, Joel S Parker, et al.
Nature Medicine|May 3, 2016
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylationGeorge P Souroullas, William R Jeck, Joel S Parker, et al.
Journal of Geriatric Oncology|July 10, 2018
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplantAshley E Rosko, Ying Huang, Don M Benson, et al.
Journal of Geriatric Oncology|November 6, 2024
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancyAshley E Rosko, Ying Huang, Sarah A Wall, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Leukemia|April 9, 2016
Loss of wild-type Kras promotes activation of all Ras isoforms in oncogenic Kras-induced leukemogenesisG Kong, Y-I Chang, A Damnernsawad, et al.
Molecular Cancer Therapeutics|February 3, 2017
The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint InhibitorsMatthew R Farren, Rebecca C Hennessey, Reena Shakya, et al.
Pigment Cell & Melanoma Research|June 21, 2023
The OSUMMER lines: A series of ultraviolet-accelerated NRAS-mutant mouse melanoma cell lines syngeneic to C57BL/6Brandon M Murphy, Daelin M Jensen, Tiffany E Arnold, et al.
Oncotarget|March 5, 2016
Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cellsDario Palmieri, Mario Scarpa, Anna Tessari, et al.
Brain, Behavior, and Immunity|June 9, 2026
Is a happy marriage a double-edged sword for biological aging? Preliminary evidence for the moderating role of couples' health behaviorsStephanie J Wilson, Annelise A Madison, M Rosie Shrout, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2019
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple MyelomaFabienne Lucas, Michael Pennell, Ying Huang, et al.
Nature Medicine|February 21, 2024
Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylationGeorge P Souroullas, William R Jeck, Joel S Parker, et al.
Nature Medicine|May 3, 2016
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylationGeorge P Souroullas, William R Jeck, Joel S Parker, et al.
Journal of Geriatric Oncology|July 10, 2018
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplantAshley E Rosko, Ying Huang, Don M Benson, et al.
Journal of Geriatric Oncology|November 6, 2024
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancyAshley E Rosko, Ying Huang, Sarah A Wall, et al.
Pageof 8